The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 2, 2014, Pages 154-163

  Rajagopalan, Krithika ^a,d   Qiu, Ruoyi ^c   Mooney, Steven M ^a   Rao, Shweta ^a   Shiraishi, Takumi ^a   Sacho, Elizabeth ^c   Huang, Hongying ^b   Shapiro, Ellen ^b   Weninger, Keith R ^c   Kulkarni, Prakash ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d Columbia University ^*  (United States)

Author keywords

C Jun; Cancer Testis Antigen; Intrinsically disordered protein; PAGE4; Prostate cancer; SmFRET

Indexed keywords

CARDIOLIPIN; DNA; HEAT SHOCK PROTEIN; PROSTATE ASSOCIATED GENE 4; PROSTATE PROTEIN; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; STRESS RESPONSE PROTEIN PROSTATE ASSOCIATED GENE 4; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; BIOPHYSICS; CELL ASSAY; CELLULAR STRESS RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE DISRUPTION; GENE INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN BINDING; PROTEIN INTERACTION; PROTO ONCOGENE; QUANTUM YIELD; REAL TIME POLYMERASE CHAIN REACTION; TRANSACTIVATION; UPREGULATION;

BENIGN PROSTATIC HYPERPLASIA; BOVINE SERUM ALBUMIN; BPH; BSA; C-JUN; CANCER/TESTIS ANTIGEN; CD; CIRCULAR DICHROISM; DBD; DIMETHYL SULFOXIDE; DLS; DMSO; DNA-BINDING DOMAIN; DYNAMIC LIGHT SCATTERING; INTRINSICALLY DISORDERED PROTEIN; IPTG; ISOPROPYL 1-THIO-Β-D-GALACTOPYRANOSIDE; NMR; NUCLEAR MAGNETIC RESONANCE; PAGE4; PBS; PC; PCA; PE; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PIA; PIN; PINS; POLYVINYL PYROLLIDONE; PROLIFERATIVE INFLAMMATORY ATROPHY; PROSTATE ASSOCIATED GENE 4; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN INTERACTION NETWORKS; PVP; QUANTUM YIELD; QY; SDS-PAGE; SEC; SINGLE-MOLECULE FÖRSTER RESONANCE ENERGY TRANSFER; SIZE EXCLUSION CHROMATOGRAPHY; SMFRET; SODIUM DODECYL SULFATE POLY-ACRYLAMIDE GEL ELECTROPHORESIS; TCEP·HCL; TRIS(2-CARBOXYETHYL)PHOSPHINE HYDROCHLORIDE;

3' UNTRANSLATED REGIONS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MUTATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PHYSIOLOGICAL; TRANSCRIPTIONAL ACTIVATION;

EID: 84890141083     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.11.014     Document Type: Article

References (70)

1. Kulkarni P., Shiraishi T., Rajagopalan K., Kim R., Mooney S.M., Getzenberg R.H. Cancer/testis antigens and urological malignancies. Nat. Rev. Urol. 2012, 9:386-396.
2. Simpson A.J., Caballero O.L., Jungbluth A., Chen Y.T., Old L.J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 2005, 5:615-625.
3. Scanlan M.J., Gure A.O., Jungbluth A.A., Old L.J., Chen Y.T. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 2002, 188:22-32.
4. Suyama T., Shiraishi T., Zeng Y., Yu W., Parekh N., Vessella R.L., Luo J., Getzenberg R.H., Kulkarni P. Expression of cancer/testis antigens in prostate cancer is associated with disease progression. Prostate 2010, 70:1778-1787.
5. Sampson N., Ruiz C., Zenzmaier C., Bubendorf L., Berger P. PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer. Am. J. Pathol. 2012, 181:1443-1454.
6. Nelson W.G., De Marzo A.M., Isaacs W.B. Prostate cancer. N. Engl. J. Med. 2003, 349:366-381.
7. Rajagopalan K., Mooney S.M., Parekh N., Getzenberg R.H., Kulkarni P. A majority of the cancer/testis antigens are intrinsically disordered proteins. J. Cell. Biochem. 2011, 112:3256-3267.
8. Zeng Y., He Y., Yang F., Mooney S.M., Getzenberg R.H., Orban J., Kulkarni P. The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J. Biol. Chem. 2011, 286:13985-13994.
9. Uversky V.N. Unusual biophysics of intrinsically disordered proteins. Biochim. Biophys. Acta 2013, 1834:932-951.
10. Tompa P. Intrinsically disordered proteins: a 10-year recap. Trends Biochem. Sci. 2012, 37:509-516.
11. Uversky V.N., Oldfield C.J., Dunker A.K. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 2008, 37:215-246.
12. Patil A., Kinoshita K., Nakamura H. Hub promiscuity in protein-protein interaction networks. Int. J. Mol. Sci. 2010, 11:1930-1943.
13. Haynes C., Oldfield C.J., Ji F., Klitgord N., Cusick M.E., Radivojac P., Uversky V.N., Vidal M., Iakoucheva L.M. Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput. Biol. 2006, 2:e100.
14. Tompa P., Csermely P. The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 2004, 18:1169-1175.
15. Edwards Y.J., Lobley A.E., Pentony M.M., Jones D.T. Insights into the regulation of intrinsically disordered proteins in the human proteome by analyzing sequence and gene expression data. Genome Biol. 2009, 10:R50.
16. Babu M.M., van der Lee R., de Groot N.S., Gsponer J. Intrinsically disordered proteins: regulation and disease. Curr. Opin. Struct. Biol. 2011, 21:432-440.
17. Yoon M.K., Venkatachalam V., Huang A., Choi B.S., Stultz C.M., Chou J.J. Residual structure within the disordered C-terminal segment of p21(Waf1/Cip1/Sdi1) and its implications for molecular recognition. Protein Sci. 2009, 18:337-347.
18. Nath A., Sammalkorpi M., DeWitt D.C., Trexler A.J., Elbaum-Garfinkle S., O'Hern C.S., Rhoades E. The conformational ensembles of alpha-synuclein and tau: combining single-molecule FRET and simulations. Biophys. J. 2012, 103:1940-1949.
19. Libich D.S., Harauz G. Backbone dynamics of the 18.5kDa isoform of myelin basic protein reveals transient alpha-helices and a calmodulin-binding site. Biophys. J. 2008, 94:4847-4866.
20. Lee C.W., Ferreon J.C., Ferreon A.C., Arai M., Wright P.E. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19290-19295.
21. Lee C.W., Arai M., Martinez-Yamout M.A., Dyson H.J., Wright P.E. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Biochemistry 2009, 48:2115-2124.
22. Huang F., Rajagopalan S., Settanni G., Marsh R.J., Armoogum D.A., Nicolaou N., Bain A.J., Lerner E., Haas E., Ying L., Fersht A.R. Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20758-20763.
23. Grupi A., Haas E. Segmental conformational disorder and dynamics in the intrinsically disordered protein alpha-synuclein and its chain length dependence. J. Mol. Biol. 2011, 405:1267-1283.
24. Ferreon A.C., Gambin Y., Lemke E.A., Deniz A.A. Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5645-5650.
25. Andresen C., Helander S., Lemak A., Fares C., Csizmok V., Carlsson J., Penn L.Z., Forman-Kay J.D., Arrowsmith C.H., Lundstrom P., Sunnerhagen M. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding. Nucleic Acids Res. 2012, 40:6353-6366.
26. Vavouri T., Semple J.I., Garcia-Verdugo R., Lehner B. Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 2009, 138:198-208.
27. Iakoucheva L.M., Brown C.J., Lawson J.D., Obradovic Z., Dunker A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323:573-584.
28. Marcotte E.M., Tsechansky M. Disorder, promiscuity, and toxic partnerships. Cell 2009, 138:16-18.
29. Munsky B., Neuert G., van Oudenaarden A. Using gene expression noise to understand gene regulation. Science 2012, 336:183-187.
30. Taniguchi Y., Choi P.J., Li G.W., Chen H., Babu M., Hearn J., Emili A., Xie X.S. Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science 2010, 329:533-538.
31. Ladbury J.E., Arold S.T. Noise in cellular signaling pathways: causes and effects. Trends Biochem. Sci. 2012, 37:173-178.
32. Mahmoudabadi G., Rajagopalan K., Getzenberg R.H., Hannenhalli S., Rangarajan G., Kulkarni P. Intrinsically disordered proteins and conformational noise: implications in cancer. Cell Cycle 2013, 12:26-31.
33. Mooney S.M., Goel A., D'Assoro A.B., Salisbury J.L., Janknecht R. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J. Biol. Chem. 2010, 285:30443-30452.
34. O'Neill H.A., Gakh O., Park S., Cui J., Mooney S.M., Sampson M., Ferreira G.C., Isaya G. Assembly of human frataxin is a mechanism for detoxifying redox-active iron. Biochemistry 2005, 44:537-545.
35. Park S., Gakh O., Mooney S.M., Isaya G. The ferroxidase activity of yeast frataxin. J. Biol. Chem. 2002, 277:38589-38595.
36. Kim J.J., Yin B., Christudass C.S., Terada N., Rajagopalan K., Fabry B., Lee D.Y., Shiraishi T., Getzenberg R.H., Veltri R.W., An S.S., Mooney S.M. Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer. J. Cell. Biochem. 2013, 114:1286-1293.
37. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer, New York. 3rd ed.
38. Choi U.B., McCann J.J., Weninger K.R., Bowen M.E. Beyond the random coil: stochastic conformational switching in intrinsically disordered proteins. Structure 2011, 19:566-576.
39. Choi U.B., Weninger K.R., Bowen M.E. Immobilization of proteins for single-molecule fluorescence resonance energy transfer measurements of conformation and dynamics. Methods Mol. Biol. 2012, 896:3-20.
40. Li Y., Augustine G.J., Weninger K. Kinetics of complexin binding to the SNARE complex: correcting single molecule FRET measurements for hidden events. Biophys. J. 2007, 93:2178-2187.
41. McCann J.J., Choi U.B., Zheng L., Weninger K., Bowen M.E. Optimizing methods to recover absolute FRET efficiency from immobilized single molecules. Biophys. J. 2010, 99:961-970.
42. Gopich I.V., Szabo A. Photon counting histograms for diffusing fluorophores. J. Phys. Chem. B 2005, 109:17683-17688.
43. Mooney S.M., Grande J.P., Salisbury J.L., Janknecht R. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 2010, 49:1-10.
44. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 2007, 23716-23724.
45. Terada N., Shiraishi T., Zeng Y., Mooney S.M., Yeater D.B., Mangold L.A., Partin A.W., Kulkarni P., Getzenberg R.H. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness. Prostate 2012, 72:966-976.
46. Prakash K., Pirozzi G., Elashoff M., Munger W., Waga I., Dhir R., Kakehi Y., Getzenberg R.H. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7598-7603.
47. Uversky V.N. Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 2002, 11:739-756.
48. Graneli A., Yeykal C.C., Prasad T.K., Greene E.C. Organized arrays of individual DNA molecules tethered to supported lipid bilayers. Langmuir 2006, 22:292-299.
49. Boukobza E., Sonnenfeld A., Haran G. Immobilization in surface-tethered lipid vesicles as a new tool for single biomolecule spectroscopy. J. Phys. Chem. B 2001, 105:12165-12170.
50. Choi U.B., Strop P., Vrljic M., Chu S., Brunger A.T., Weninger K.R. Single-molecule FRET-derived model of the synaptotagmin 1-SNARE fusion complex. Nat. Struct. Mol. Biol. 2010, 17:318-324.
51. Grosberg A.I.U., Khokhlov A.R. Statistical Physics of Macromolecules 1994, AIP Press, New York.
52. Flory P.J. Statistical Mechanics of Chain Molecules 1969, Interscience Publishers, New York.
53. Wilkins D.K., Grimshaw S.B., Receveur V., Dobson C.M., Jones J.A., Smith L.J. Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 1999, 38:16424-16431.
54. Huang C., Wang Y., Li D., Li Y., Luo J., Yuan W., Ou Y., Zhu C., Zhang Y., Wang Z., Liu M., Wu X. Inhibition of transcriptional activities of AP-1 and c-Jun by a new zinc finger protein ZNF394. Biochem. Biophys. Res. Commun. 2004, 320:1298-1305.
55. Minden A., Lin A., McMahon M., Lange-Carter C., Derijard B., Davis R.J., Johnson G.L., Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994, 266:1719-1723.
56. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p 38-Mpk2. Science 1995, 268:286-290.
57. Alani R., Brown P., Binetruy B., Dosaka H., Rosenberg R.K., Angel P., Karin M., Birrer M.J. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 1991, 11:6286-6295.
58. Zigoneanu I.G., Yang Y.J., Krois A.S., Haque E., Pielak G.J. Interaction of alpha-synuclein with vesicles that mimic mitochondrial membranes. Biochim. Biophys. Acta 2012, 1818:512-519.
59. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., Taccioli C., Pichiorri F., Alder H., Secchiero P., Gasparini P., Gonelli A., Costinean S., Acunzo M., Condorelli G., Croce C.M. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009, 16:498-509.
60. Pineau P., Volinia S., McJunkin K., Marchio A., Battiston C., Terris B., Mazzaferro V., Lowe S.W., Croce C.M., Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:264-269.
61. Galardi S., Mercatelli N., Farace M.G., Ciafre S.A. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res. 2011, 39:3892-3902.
62. Sato N., Sadar M.D., Bruchovsky N., Saatcioglu F., Rennie P.S., Sato S., Lange P.H., Gleave M.E. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem. 1997, 272:17485-17494.
63. Chen S.Y., Cai C., Fisher C.J., Zheng Z., Omwancha J., Hsieh C.L., Shemshedini L. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene 2006, 25:7212-7223.
64. Cai C., Hsieh C.L., Shemshedini L. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer. Mol. Cancer Res. 2007, 5:725-735.
65. Li W., Wu C.L., Febbo P.G., Olumi A.F. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Am. J. Pathol. 2007, 171:1189-1198.
66. Edwards J., Krishna N.S., Mukherjee R., Bartlett J.M. The role of c-Jun and c-Fos expression in androgen-independent prostate cancer. J. Pathol. 2004, 204:153-158.
67. Sun T., Yang M., Chen S., Balk S., Pomerantz M., Hsieh C.L., Brown M., Lee G.S., Kantoff P.W. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Prostate 2012, 72:1093-1103.
68. Ouyang X., Jessen W.J., Al-Ahmadie H., Serio A.M., Lin Y., Shih W.J., Reuter V.E., Scardino P.T., Shen M.M., Aronow B.J., Vickers A.J., Gerald W.L., Abate-Shen C. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 2008, 68:2132-2144.
69. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997, 9:240-246.
70. Ciapponi L., Bohmann D. An essential function of AP-1 heterodimers in Drosophila development. Mech. Dev. 2002, 115:35-40.